Farther Finance Advisors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.11K Buy
2,358
+107
+5% +$317 ﹤0.01% 4690
2026
Q1
$6.98K Buy
2,251
+2,168
+2,612% +$9.39K ﹤0.01% 4320
2025
Q4
$295 Sell
83
-47
-36% -$288 ﹤0.01% 5142
2025
Q3
$1.16K Buy
130
+90
+225% +$913 ﹤0.01% 4325
2025
Q2
$369 Hold
40
﹤0.01% 4100
2025
Q1
$321 Hold
40
﹤0.01% 3857
2024
Q4
$430 Hold
40
﹤0.01% 3466
2024
Q3
$227 Hold
40
﹤0.01% 3629
2024
Q2
$164 Hold
40
﹤0.01% 3524
2024
Q1
$201 Sell
40
-4
-9% -$23 ﹤0.01% 3273
2023
Q4
$410 Buy
+44
New +$303 ﹤0.01% 3035

Other funds holding AVXL

Farther Finance Advisors's AVXL Position: Q2 2026 in Review

Farther Finance Advisors increased its Anavex Life Sciences (AVXL) stake by 4.8% in Q2 2026, buying an estimated $317 and bringing the position to 2,358 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4690.

Farther Finance Advisors first reported a position in AVXL in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.98K in Q1 2026. 29 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Farther Finance Advisors held 2,358 shares of Anavex Life Sciences worth $6.11K as of Q2 2026.
  • Farther Finance Advisors bought 107 Anavex Life Sciences shares in Q2 2026, an estimated $317.
  • Anavex Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4690 holding.
  • Farther Finance Advisors first reported a position in Anavex Life Sciences in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Anavex Life Sciences position peaked at $6.98K in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.